ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

CordenPharma Buys Carbohydrate Firm

by Michael McCoy
November 18, 2013 | APPEARED IN VOLUME 91, ISSUE 46

Contract drug manufacturer CordenPharma has acquired Ancora Pharmaceuticals, a carbohydrate synthesis specialist based in Woburn, Mass. Corden intends to mesh Ancora’s synthesis expertise with its own process development, scale-up, and manufacturing capabilities to become the leading supplier of synthetic carbohydrates. Applications include glycoconjugate vaccine antigens, nutraceuticals, and diagnostics. Services will be offered from Ancora’s Woburn facility and Corden plants in the U.S. and Europe.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment